On ECHEMI
Home > Drugs > Jiangxi Renqi Pharmaceutical Co., Ltd.
Jiangxi Renqi Pharmaceutical Co., Ltd.
  • Founded in:

    2001-05-30
  • Country:

    China China
  • Address:

    No. 8 Road, Chengbei Industrial Park, Zhangshu City, Jiangxi Province
  • Tax NO.:

    91360900716598386X
  • Registered Funds:

    6.23540698 yuan
  • Email:

Related Drugs
Chondroitin Sulfate Sodium Tablets
It is an acidic mucopolysaccharide extracted from the cartilage tissue of the pig's larynx, nasal bone, trachea, etc. The hexose amino content of this product is calculated as glucosamine (C6H13O5N), which shall not be less than 24.0% of the labeled amount of chondroitin sulfate.
Name Description Content CAS NO. Registered Holders
Chondroitin 4-sulfate

1. Remove lipids and lipoproteins from the blood, remove cholesterol from the blood vessels around the heart, prevent and treat atherosclerosis, and increase the conversion rate of lipids and fatty acids in cells; 2. Prevent and treat coronary heart disease, resist atherosclerosis and the formation of atherosclerotic plaques, increase coronary artery branches or collateral circulation, and accelerate the healing, regeneration and repair of myocardial necrosis or degeneration; 3. Increase the biosynthesis of cellular mRNA and DNA, and promote cell metabolism; 4. Has a mild anticoagulant effect (each 1 mg of chondroitin sulfate A is equivalent to the anticoagulant activity of 0.45U heparin); 5. Has anti-inflammatory, accelerated wound healing and anti-tumor effects.

More

1. Remove lipids and lipoproteins from the blood, remove cholesterol from the blood vessels around the heart, prevent and treat atherosclerosis, and increase the conversion rate of lipids and fatty acids in cells; 2. Prevent and treat coronary heart disease, resist atherosclerosis and the formation of atherosclerotic plaques, increase coronary artery branches or collateral circulation, and accelerate the healing, regeneration and repair of myocardial necrosis or degeneration; 3. Increase the biosynthesis of cellular mRNA and DNA, and promote cell metabolism; 4. Has a mild anticoagulant effect (each 1 mg of chondroitin sulfate A is equivalent to the anticoagulant activity of 0.45U heparin); 5. Has anti-inflammatory, accelerated wound healing and anti-tumor effects.

24.0%Chondroitin sulfate labeled amount 9007-28-7 2
Cephalexin and Trimethoprim Capsules
Each tablet contains 125mg of cephalexin and 25mg of trimethoprim
Name Description Content CAS NO. Registered Holders
Cephalexin

By inhibiting bacterial transpeptidase, it prevents the synthesis of bacterial cell walls, inhibits or kills bacteria; when used with trimethoprim, it improves antibacterial ability, delays the development of drug resistance, and reduces oral doses

More

By inhibiting bacterial transpeptidase, it prevents the synthesis of bacterial cell walls, inhibits or kills bacteria; when used with trimethoprim, it improves antibacterial ability, delays the development of drug resistance, and reduces oral doses

125mg 15686-71-2 33
Trimethoprim

By inhibiting bacterial transpeptidase, it prevents the synthesis of bacterial cell walls, inhibits or kills bacteria; when used with cephalexin, it can improve antibacterial ability, delay the development of drug resistance, and reduce oral dosage

More

By inhibiting bacterial transpeptidase, it prevents the synthesis of bacterial cell walls, inhibits or kills bacteria; when used with cephalexin, it can improve antibacterial ability, delay the development of drug resistance, and reduce oral dosage

25mg 738-70-5 44
Artificial bezoar
Name Description Content CAS NO. Registered Holders
Atificial Cow-bezoar

1002-00-2 2
Berberine Hydrochloride Tablets
Each tablet of this product contains 0.1g of berberine hydrochloride as the main ingredient, and the auxiliary materials are starch, hydroxypropyl cellulose, micro-powder silica gel, magnesium stearate, sucrose, talcum powder, dextrin, pigment, and tartrazine. Chemical name: berberine hydrochloride Molecular formula: C20H18C1NO4 Molecular weight: 371.82
Name Description Content CAS NO. Registered Holders
Berberine hydrochloride

Effective for intestinal infections caused by Shigella dysenteriae and Escherichia coli

More

Effective for intestinal infections caused by Shigella dysenteriae and Escherichia coli

0.1g 633-65-8 46
Norfloxacin Capsules
Norfloxacin
Name Description Content CAS NO. Registered Holders
Norfloxacin

This product is a fluoroquinolone antibacterial drug with a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacteria. It has good antibacterial activity against the following bacteria in vitro: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes and other Enterobacter species, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. Norfloxacin also has antibacterial activity against multi-drug resistant bacteria in vitro. It also has good antibacterial effects on penicillin-resistant Neisseria gonorrhoeae, Haemophilus influenzae and Moraxella catarrhalis. Norfloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

More

This product is a fluoroquinolone antibacterial drug with a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacteria. It has good antibacterial activity against the following bacteria in vitro: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes and other Enterobacter species, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. Norfloxacin also has antibacterial activity against multi-drug resistant bacteria in vitro. It also has good antibacterial effects on penicillin-resistant Neisseria gonorrhoeae, Haemophilus influenzae and Moraxella catarrhalis. Norfloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

70458-96-7 35
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.